Principles of Pharmacokinetics in the Pregnant Woman and Fetus
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Clinics in Perinatology
- Vol. 46 (2) , 383-398
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Exposure to diethylstilbestrol during sensitive life stages: A legacy of heritable health effectsBirth Defects Research Part C: Embryo Today: Reviews, 2013
- Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesteroneActa Obstetricia et Gynecologica Scandinavica, 2012
- Drug Interactions at the Human Placenta: What is the Evidence?Frontiers in Pharmacology, 2012
- Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproateAmerican Journal of Obstetrics and Gynecology, 2011
- Betamethasone dose and formulation for induced lung maturation in fetal sheepAmerican Journal of Obstetrics and Gynecology, 2009
- Pharmacological Treatment of the FetusClinical Pharmacokinetics, 1995
- Prenatal Prediction of Risk of the Fetal Hydantoin SyndromeNew England Journal of Medicine, 1990
- Effect of pregnancy on gastrointestinal transitDigestive Diseases and Sciences, 1982
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- Diphenylhydantoin: Placental transport, fetallocalization, neonatal metabolism, and possible teratogenic effectsThe Journal of Pediatrics, 1971